Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors-Reference-Cited by-同舟云学术

Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors

Published:2012-12 Issue: Volume:76 Page:125-140
ISSN:1874-3919
Container-title:Journal of Proteomics
language:en
Short-container-title:Journal of Proteomics

Author:

Gianazza Erica,Chinello Clizia,Mainini Veronica,Cazzaniga Marta,Squeo Valeria,Albo Giancarlo,Signorini Stefano,Di Pierro Salvatore S.,Ferrero Stefano,Nicolardi Simone,van der Burgt Yuri E.M.,Deelder André M.,Magni Fulvio

Funder

Italian Ministry of University and Research

Italian Institute of Technology

Publisher

Elsevier BV

Subject

Biochemistry,Biophysics

Reference82 articles.

1. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review;Gupta;Cancer Treat Rev,2008

2. Renal cell carcinoma;Rini;Lancet,2009

3. Key clinical issues in renal cancer: a challenge for proteomics;Banks;World J Urol,2007

4. Recent updates in renal cell carcinoma;Rathmell;Curr Opin Oncol,2010

5. Renal cell carcinoma: recent progress and future directions;Mulders;Cancer Res,1997

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of zyxin in signal transduction and its relationship with diseases;Frontiers in Molecular Biosciences;2024-04-22

2. Peptidomic Analysis and Potential Bioactive Peptides Identification Targeting Endometrial Cancer;International Journal of Peptide Research and Therapeutics;2023-11-13

3. Role of proteomics in surgical oncology;Proteomics;2023

4. Advanced Nanomaterials for the Diagnosis and Treatment of Renal Cell Carcinoma;Advanced NanoBiomed Research;2022-12-21

5. Utilizing MALDI-TOF MS and LC-MS/MS to access serum peptidome-based biomarkers in canine oral tumors;Scientific Reports;2022-12-14